Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation

Yakugaku Zasshi

Volumn 128, Issue 9, 2008, Pages 1293-1299

  Luo, Pei ^a   Tan, Zheng Huai ^b   Zhang, Zhi Feng ^a   Zhang, Hao ^a   Liu, Xian Fu ^c   Mo, Zheng Ji ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Institute of Chinese Materia Medica   (China)

^c West China School of Pharmacy   (China)

Author keywords

Adhesion molecule; Endothelial cell; Nuclear factor kappa B; Scutellarin

Indexed keywords

ALLOXAN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SCUTELLAREIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ERIGERON; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MOUSE; NONHUMAN;

ANIMALS; APIGENIN; ARTERITIS; CELL ADHESION; CELLS, CULTURED; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ERIGERON; GLUCOSE; GLUCURONIC ACIDS; HUMANS; HYPERGLYCEMIA; INTERCELLULAR ADHESION MOLECULE-1; MICE; NF-KAPPA B; PHYTOTHERAPY;

EID: 50849140182     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.1293     Document Type: Article

References (35)

1. Calles-Escandon J., Cipolla M., Endocr. Rev., 22, 36-52 (2001).
2. Feener E. P., King G. L., Heart Fail Monit., 1, 74-82 (2001).
3. Rojas A., Morales M. A., Life Sci., 76, 715-730 (2004).
4. Gokce G., Haznedaroglu M. Z., J. Ethnopharmacol., 115, 122-130 (2008).
5. Kannel W. B., McGee D. L., JAMA, 241, 2035-2038 (1979).
6. Nomura S., Suzuki M., Katsura K., Xie G. L., Miyazaki Y., Miyake T., Kido H., Kagawa H., Fukuhara S., Atherosclerosis, 116, 235-40 (1995).
7. Tkaác I., Kimball B. P., Lewis G., Uffelman K., Steiner G., Arterioscler. Thromb. Vasc. Bio., 17, 3633-3638 (1997).
8. Lum H., Malik A. B., Am. J. Physiol., 267, 223-241 (1994)
9. Lopes-Virella M. F., Virella G., Diabetes, 41, Suppl 2, 86-91 (1992).
10. Quagliaro L., Piconi L., Assaloni R., Martinelli L., Motz E., Ceriello A., Diabetes, 52, 2795-2804 (2003).
11. Ling R., Chen Y. L., Flora of China, 74, 299-311 (1985).
12. "Dimaer·Danzengpengcuo," Jingzhu Herbal, Science and Technology Press, Shanghai, 1986, pp. 115-116.
13. Zhang Y. J., Li L. Q., Yang P. Q., Zhang H., Acta Pharm. Sin., 33, 836-838 (1988).
14. Zhang Y. J., Li L. Q., Yang P. Q., Zhang H., Chin. Trad. Herbal Drugs, 29, 798-800 (1988).
15. Zhang Z. F., Zhang H., Hu Y. H., Liu X. F., Chin. J. Ethnomed. Ethnopharm., 61, 111-112 (2003).
16. Xu M., Huang Z. H., Chin. J. New Drugs Clin. Rem., 10, 260-263 (1991).
17. Liu Y. M., Lin A. H., Chen H., Zeng F. D., Acta. Pharm. Sin., 38, 775-778 (2003).
18. Chen X. X., He B., J. Chi. Pharm. Sci., 7, 91-93 (1998).
19. Moreno-Manzano V., Ishikawa Y., Lucio-Cazana J., Kitamura M., J. Biol. Chem., 274, 20251-20258 (1999).
20. Mosmann T., J. Immunol. Methods, 65, 55-63 (1983).
21. Cybulsky M. I., Gimbrone M. A., Science, 251, 788-791 (1991).
22. Goldrosen M. H., Biddle W. C., Pancook J., Bakshi S., Vanderheyden J. L., Fritzberg A. R., Morgan A. C., Foon K. A., Cancer Res., 50, 7973-7978 (1990).
23. Rothlein R., Czajkowski M., O'Neill M. M., Marlin S. D., Mainolfi E., Merluzzi V. J., J. Immunol., 141, 1665-1669 (1988).
24. Kim S. O., Kundu J. K., Shin Y. K., Park J. H., Cho M. H., Kim T. Y., Surh Y. J., Oncogene, 24, 2558-2567 (2005).
25. Zardi E. M., Zardi D. M., Cacciapaglia F., Dobrina A., Amoroso A., Picardi A., Afeltra A., Int. Immunopharmacol., 5, 437-459 (2005).
26. Kim J. A., Berliner J. A., Natarajan R. D., Nadler J. L., Diabetes, 43, 1103-1107 (1994).
27. Boisvert J., Edmondson S., Krummel M. F., J. Immunol., 173, 3647-3652 (2004).
28. Takami S., Yamashita S., Kihara S., Kameda-Takemura K., Matsuzawa Y. Atherosclerosis, 138, 35-41 (1998).
29. Cominacini L., Fratta Pasini A., Garbin U., Davoli A., De Santis A., Campagnola M., Rigoni A., Zenti M. G., Moghetti P., Lo Cascio V., Diabetologia, 38, 1122-1124 (1995).
30. Davies M. J., Gordon J. L., Gearing A. J. H., J. Pathol., 171, 223-229 (1993).
31. Shanmugam N., Reddy M. A., Guha M., Natarajan R., Diabetes, 52, 1256-1264 (2003).
32. Gosh S., Baltimore D., Nature, 344, 678-682 (1990).
33. Iwasaki Y., Asai M., Yoshida M., Nigawara T., Kambayashi M., Nakashima N., J. Clin. Endocrinol. Metab., 89, 3449-3454 (2004).
34. Morigi M., Angioletti S., Imberti B., Donadelli R., Micheletti G., Figliuzzi M., Remuzzi A., Zoja C., Remuzzi G., J. Clin. Invest., 101, 1905-1915 (1998).
35. Auwardt R. B., Mudge S. J., Chen C., Power D. A., Exp. Nephrol., 8, 144-151 (2008).